Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000950170-24-028171
Filing Date
2024-03-07
Accepted
2024-03-07 17:34:26
Documents
1
Period of Report
2024-03-07

Document Format Files

Seq Description Document Type Size
1 4 ownership.html 4  
1 4 ownership.xml 4 10345
  Complete submission text file 0000950170-24-028171.txt   11827
Mailing Address 3595 JOHN HOPKINS COURT SAN DIEGO CA 92121
Business Address
MAIER PAUL V (Reporting) CIK: 0001182615 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-56600 | Film No.: 24731470

Mailing Address 10975 NORTH TORREY PINES ROAD LA JOLLA CA 92037
Business Address 10975 NORTH TORREY PINES ROAD LA JOLLA CA 92037 (858) 875-2400
Ambrx Biopharma, Inc. (Issuer) CIK: 0001990550 (see all company filings)

EIN.: 932892120 | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)